Fully mobilizing host defense: building better vaccines (Q77608031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Fully mobilizing host defense: building better vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Raychaudhuri S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Rock KL

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

1025-1031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

cites work

Immunity to infection

1 reference

7 January 2021

Cancer Tumor antigens

1 reference

7 January 2021

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

1 reference

7 January 2021

Immunoglobulin G and its function in the human respiratory tract

1 reference

7 January 2021

Pneumococcal vaccine: clinical efficacy and effectiveness

1 reference

7 January 2021

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

7 January 2021

Prospects for adoptive T cell therapy

1 reference

7 January 2021

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

7 January 2021

MHC class I-restricted CTL responses to exogenous antigens

1 reference

7 January 2021

Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited

1 reference

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

7 January 2021

Antigen processing and presentation by the class I major histocompatibility complex

1 reference

7 January 2021

Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules

1 reference

7 January 2021

The cytoskeleton in mRNA localization and cell differentiation

1 reference

7 January 2021

Origin, maturation and antigen presenting function of dendritic cells.

1 reference

7 January 2021

Dendritic cells and the control of immunity

1 reference

7 January 2021

T-cell signaling: the importance of receptor clustering

1 reference

7 January 2021

Capture and processing of exogenous antigens for presentation on MHC molecules.

1 reference

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

7 January 2021

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1 reference

7 January 2021

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

1 reference

7 January 2021

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

7 January 2021

New use of BCG for recombinant vaccines

1 reference

7 January 2021

Vaccinia from recombinant virus expressing HIV genes

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

Genetic to genomic vaccination

1 reference

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

7 January 2021

Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus

1 reference

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

7 January 2021

Analysis of the association of peptides of optimal length to class I molecules on the surface of cells

1 reference

7 January 2021

Immunity to Oncogenic Proteins

1 reference

7 January 2021

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

1 reference

7 January 2021

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

7 January 2021

Association of HLA phenotype with response to active specific immunotherapy of melanoma

1 reference

7 January 2021

Immunological adjuvants: Desirable properties and side-effects

1 reference

7 January 2021

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo

1 reference

7 January 2021

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

1 reference

7 January 2021

Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin

1 reference

7 January 2021

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

1 reference

7 January 2021

The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice

1 reference

7 January 2021

Virus-like particles as a rotavirus subunit vaccine.

1 reference

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

7 January 2021

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

1 reference

7 January 2021

A protein particle vaccine containing multiple malaria epitopes

1 reference

7 January 2021

Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses

1 reference

7 January 2021

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

1 reference

7 January 2021

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

1 reference

7 January 2021

Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway

1 reference

7 January 2021

Presentation of exogenous antigen with class I major histocompatibility complex molecules

1 reference

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

7 January 2021

Antigen processing and intracellular traffic of antigens and MHC molecules

1 reference

7 January 2021

Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages.

1 reference

7 January 2021

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

1 reference

7 January 2021

The mannose receptor is a pattern recognition receptor involved in host defense

1 reference

7 January 2021

Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes

1 reference

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

7 January 2021

Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes

1 reference

7 January 2021

Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system

1 reference

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

7 January 2021

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

1 reference

7 January 2021

Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles

1 reference

7 January 2021

Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes

1 reference

7 January 2021

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

7 January 2021

Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors

1 reference

7 January 2021

Cytokines and clinical gene therapy

1 reference

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

7 January 2021

Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome

1 reference

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

7 January 2021

Interleukin-12 and up: functions of T helper subsets resulting from differential cytokine production

1 reference

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

7 January 2021

A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells

1 reference

7 January 2021

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

7 January 2021

Identifiers

DOI

10.1038/3469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9831030%20AND%20SRC:MED&resulttype=core&format=json